Old Republic International Corporation ORI
Composite 64/100; the shares have moved about 22% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Its least supportive area is Balance-sheet strength at 55 — still above average.
Valuation ranks 85/100 — a strong point in its favour. Quality ranks 64/100 — a moderate point in its favour. Momentum ranks 59/100 — a slight point in its favour.
Its least supportive area is Balance-sheet strength at 55 — still above average.
What the company does Old Republic International (ORI) underwrites specialty and title insurance across the U.S. and Canada. Its Specialty Insurance segment covers risks such as workers’ compensation, cyber, and surety, while the Title Insurance segment provides real estate title insurance and closing services.
Key financials ORI posts ROE of 18.6% and ROA of 3.1%, with gross, operating, and net margins of 63.9%, 17.4%, and 11.7%, respectively. Revenue grew 13.4% and EPS 61.7%, supported by a debt/equity ratio of 0.38 and current ratio of 0.67.
Stock health The stock shows strong momentum with 3m, 6m, and 12m gains of 9.07%, 12.32%, and 29.94%, respectively, while trading 3.24% below its 52-week high. Sidera’s Overall score is 64.7 (average quality, attractively valued), with Valuation at 84.2 and Income at 83.3.
Price vs fair value The stock trades at a discount of 33.40% to our fair-value estimate of 57.64 and a discount of 0.67% to the analyst 12-month target of 43.50. - Discount to fair value reflects the 33.40% gap (Sidera). - Discount to analyst target of 0.67% (Sidera). - High valuation percentile of 84.2/100 (Sidera). - Strong momentum with 12m return of 29.94% (Sidera). - Attractive dividend yield of 2.9% (Sidera).
Looking forward Forward P/E of 11.43 and ROE of 18.6% suggest disciplined underwriting and capital efficiency. Growth in revenue (13.4%) and EPS (61.7%) supports valuation, though margin stability and leverage remain watchpoints.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.